Skip to main content
. 2016 Jul 18;5(3):367–377. doi: 10.1007/s40121-016-0121-2

Fig. 3.

Fig. 3

In vitro activity of telavancin alone and in combination of aztreonam or piperacillin/tazobactam in MRSA ATCC 43300 (a) and a clinical strain R5255 (b). Black circle growth control, white circle telavancin, white square aztreonam, white inverted triangle piperacillin/tazobactam, black triangle telavancin + aztreonam, black inverted triangle telavancin + piperacillin/tazobactam